Royalty Pharma EVP Christopher Hite disposes of 100,000 shares worth $5,853,719.88

RPRX•2026-09-24

Royalty Pharma EVP Christopher Hite sold 100,000 Class A ordinary shares on Sept. 22 for $5,853,719.88.

1. Share sale

The sales were executed through SCH Investment Partners at prices of $58.5148 and $58.9261 per share. The investment partnership’s stake fell to 270,401 shares; Hite still held 23,200 shares directly.

Sources

Royalty Pharma EVP Christopher Hite disposes of 100,000 shares worth $5,853,719.88

Sec

Royalty Pharma EVP Christopher Hite disposes of 100,000 shares worth $5,853,719.88

1. Share sale

Related News

BankUnited declares quarterly cash dividend of $0.33 per share

Hyperscale Data executive chairman reports $55,950.52 common share purchase

Soluna Chief Accounting Officer Jessica L. Thomas disposes of 30,000 shares for $37,800

Sources

Royalty Pharma EVP Christopher Hite disposes of 100,000 shares worth $5,853,719.88

Cooper Standard appoints Matthew Boddy chief commercial officer

Neighborhood Intelligence, Fathom explore revamped deal valuing NXH digital assets at no less than $130 million